Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-Human immunodeficiency virus challenge

Journal of Infectious Diseases

Volumn 199, Issue 10, 2009, Pages 1525-1527

  Veazey, Ronald S ^a   Ling, Binhua ^a   Green, Linda C ^a   Ribka, Erin P ^a   Lifson, Jeffrey D ^b   Piatak Jr , Michael ^b   Lederman, Michael M ^c   Mosier, Donald ^d   Offord, Robin ^e   Hartley, Oliver ^f  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b SAIC FREDERICK INC   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e Mintaka Foundation for Medical Research   (Switzerland)

^f UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE; RANTES; RECOMBINANT PROTEIN; RECOMBINANT RANTES 5P12; RECOMBINANT RANTES 6P4; RECOMBINANT RANTES PSC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; EXPERIMENTAL MODEL; FEMALE; HEALTH CARE COST; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN HUMAN IMMUNODEFICIENCY VIRUS; SIMIAN IMMUNODEFICIENCY VIRUS; TOPICAL TREATMENT; TREATMENT OUTCOME; VAGINITIS; VIREMIA;

ADMINISTRATION, TOPICAL; ANIMALS; CHEMOKINE CCL5; CHEMOKINES; FEMALE; MACACA; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VAGINA; VIRAL LOAD;

EID: 65549149201     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/598685     Document Type: Article

References (18)

1. Joint United Nations Programme on HIV-AIDS (UNAIDS) and World Health Organization (WHO). AIDS epidemic update: December 2007. Geneva: UNAIDS and WHO, 2007.
2. HIV vaccine failure prompts Merck to halt trial. Nature 2007; 449:390.
3. Lederman MM, Offord RE, Hartley O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol 2006; 6:371-82.
4. Bolognesi N. AIDS gel's failure calls prevention approach into question. Nat Med 2007; 13:230.
5. Cohen J. AIDS research: microbicide fails to protect against HIV. Science 2008; 319:1026-7.
6. Grant RM, Hamer D, Hope T, et al. Whither or wither microbicides? Science 2008; 321:532-4.
7. Lederman MM, Veazey RS, Offord R, et al. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 2004; 306:485-7.
8. Veazey RS, Klasse PJ, Schader SM, et al. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 2005; 438:99-102.
9. Hartley O, Gaertner H, Wilken J, et al. Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors. Proc Natl Acad Sci USA 2004; 101:16460-5.
10. Moore JP. Topical microbicides become topical. N Engl J Med 2005; 352:298-300.
11. Schafer T, Borchert TW, Nielsen VS, et al. Industrial enzymes. Adv Biochem Eng Biotechnol 2007; 105:59-131.
12. Gaertner H, Cerini F, Kuenzi G, et al. Highly potent, fully recombinant anti-HIV chemokines: re-engineering a low-cost microbicide. Proc Natl Acad Sci USA 2008; 105:17706-11.
13. Veazey RS, Klasse PJ, Ketas TJ, et al. Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. J Exp Med 2003; 198:1551-62.
14. Institute of Laboratory Animal Research, Commission on Life Sciences, National Research Council. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press, 1996.
15. Cline AN, Bess JW, Piatak M Jr, Lifson JD. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS. J Med Primatol 2005; 34:303-12.
16. Ling B, Santiago ML, Meleth S, et al. Noninvasive detection of new simian immunodeficiency virus lineages in captive sooty mangabeys: ability to amplify virion RNA from fecal samples correlates with viral load in plasma. J Virol 2003; 77:2214-26.
17. Cerini F, Landay A, Lederman MM, et al. Evaluating the stability of chemokine-based microbicides. J Acquir Immune Defic Syndr 2008; 49: 472-6.
18. Lederman MM, Penn-Nicholson A, Cho M, Mosier D. Biology of CCR5 and its role in HIV infection and treatment. JAMA 2006; 296:815-26.